Verbena Officinalis Homeopathic Pills Fail Identification Testing
Washington Homeopathic Products is recalling 3 bottles of Verbena Officinalis 6X (Lot #29060, expiration 8/17/2026) distributed nationwide due to out-of-specification test results in identification testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall. No illnesses, injuries, or deaths are reported in the source text. The defect (out-of-specification identification testing) is a quality-control issue without documented harm, qualifying this as a moderate precautionary recall.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling 3 bottles of Verbena Officinalis 6X, Nervousness* Sucrose/Lactose Pills, Packaged 2 Dram (WHP Homeopathic Medicine) due to out-of-specification test results obtained during identification testing based on HPTLC analysis.
The affected product is Lot #29060 with expiration date 8/17/2026. The product was distributed nationwide in the USA.
The manufacturer has identified that the product failed identification testing, indicating that the product composition or purity does not meet specifications. Consumers who have purchased this product should discontinue use and consult with a healthcare provider or the manufacturer for guidance on next steps.
The recalled product
- Product
- Verbena Officinalis 6X, Nervousness* Sucrose/Lactose Pills, Packaged 2 Dram, WHP Homeopathic Medicine, Washington Hoemopathis Producs, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- specification-failure
- identification-testing-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 29060
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27